BCL2L1 and acute myeloid leukemia: We then asked ourselves whether ABT-263 or Bcl-xL silencing could be effective against drug resistance seen with other polyploidy-inducers such as ZM447439, an Aurora selective ATP-competitive inhibitor [32] that induces polyploidy through mitotic slippage in AML cell lines (Figure 5A and 5B).